Filing Details

Accession Number:
0001055726-19-000044
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-05-23 16:21:35
Reporting Period:
2019-05-21
Accepted Time:
2019-05-23 16:21:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1055726 Inovio Pharmaceuticals Inc. INO Surgical & Medical Instruments & Apparatus (3841) 330969592
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1464549 Joseph Jong Kim 660 W. Germantown Pike Suite 110
Plymouth Meeting PA 19462
Chief Executive Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-05-21 100,000 $3.31 2,411,055 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,613,232 Indirect By Family Limited Partnership
Common Stock 33,563 Indirect By Daughter: EK
Common Stock 33,775 Indirect By Son: JK1
Common Stock 5,975 Indirect By Spouse
Common Stock 33,533 Indirect By Son: JK2
Footnotes
  1. The sales reported in this Form 4 were made by a broker, without instruction by the reporting person, to satisfy a margin call by the broker, to whom these shares were pledged as collateral for a margin loan.
  2. These transactions were executed in multiple trades at prices ranging from $3.30 to $3.33, inclusive. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected.